2-(吖啶-9-基氨基)乙酸 | 55468-69-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 2-(吖啶-9-基氨基)乙酸
• 英文名称: N-(acridin-9-yl)glycine
• 英文别名: 2-(Acridin-10-ium-9-ylamino)acetate
• CAS: 55468-69-4
• 化学式: C₁₅H₁₂N₂O₂
• 分子量: 252.272
• InChiKey: KWTFIXMUBIMLGT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  62.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  9-氯吖啶 在 甲醇 、 水 作用下， 生成 2-(吖啶-9-基氨基)乙酸
  参考文献：
  名称：

  Barber et al., Journal of the Society of Chemical Industry, 1947, vol. 66, p. 411,413

  摘要：

  DOI：

文献信息

• [EN] 9-AMINOACRIDINE DERIVATIVES, THEIR PREPARATION AND USES<br/>[FR] DÉRIVÉS DE 9-AMINOACRIDINE, LEUR PRÉPARATION ET LEURS UTILISATIONS
  申请人：UNIV ARIEL RES & DEV CO LTD

  公开号：WO2011051950A1

  公开（公告）日：2011-05-05

  N-substituted 9-aminoacridine and bis-acridino derivatives containing electron- withdrawing groups (EWG) or electron-donating groups (EDG), including amino acid residues, and one-pot methods for their synthesis are disclosed. The derivatives are potential candidates for cancer treatment.

  含有取代基的9-氨基吖啶和含有电子吸引基团（EWG）或电子供给基团（EDG）的双吖啶衍生物，包括氨基酸残基，以及它们的合成的一锅法被披露。这些衍生物是潜在的癌症治疗候选物。
• BATCH DEVICES FOR THE REDUCTION OF COMPOUNDS FROM BIOLOGICAL COMPOSITIONS CONTAINING CELLS AND METHODS OF USE
  申请人：——

  公开号：US20010018179A1

  公开（公告）日：2001-08-30

  Methods and devices are provided for reducing the concentration of low molecular weight compounds in a biological composition containing cells while substantially maintaining a desired biological activity of the biological composition. The device comprises highly porous adsorbent particles, and the adsorbent particles are immobilized by an inert matrix.

  提供了一种方法和装置，用于在基于细胞的生物组成物中减少低分子量化合物的浓度，同时基本维持所需的生物活性。该装置包括高度多孔吸附剂颗粒，并且这些吸附剂颗粒被惰性基质固定。
• 9-AMINOACRIDINE DERIVATIVES, THEIR PREPARATION AND USES
  申请人：Gellerman Gary

  公开号：US20120220537A1

  公开（公告）日：2012-08-30

  N-substituted 9-aminoacridine and bis-acridino derivatives containing electron-withdrawing groups (EWG) or electron-donating groups (EDG), including amino acid residues, and one-pot methods for their synthesis are disclosed. The derivatives are potential candidates for cancer treatment.

  本发明公开了含有电子吸引基团（EWG）或电子供给基团（EDG），包括氨基酸残基的N-取代9-氨基蒽和双蒽衍生物及其一锅法合成方法。这些衍生物是癌症治疗的潜在候选物。
• Absorbents and devices for the reduction of small organic compounds from blood products
  申请人：Cerus Corporation

  公开号：EP1508345A1

  公开（公告）日：2005-02-23

  The present invention relates to a system for use in treating a blood product containing a pathogen inactivating agent comprising a biocompatible housing and an adsorbent medium having (1) adsorbent resin particles capable of adsorbing the pathogen inactivating agent, and (2) an inert matrix in which the adsorbent resin particles are immobilized; wherein the immobilized adsorbent particles have a diameter from about 100 µm to about 1200 µm when the system is configured as a batch apparatus, and the immobilized adsorbent particles have a diameter from about 1 µm to about 200 µm when the system is configured as a flow-through apparatus; and wherein said blood product substantially maintains a desired biological activity after treatment with said system.

  本发明涉及一种用于处理含有病原体灭活剂的血液制品的系统，该系统包括生物相容性外壳和吸附介质，吸附介质具有(1)能够吸附病原体灭活剂的吸附树脂颗粒，和(2)固定吸附树脂颗粒的惰性基质；其中，当系统配置为间歇式装置时，固定吸附剂颗粒的直径约为 100 µm 至约 1200 µm，而当系统配置为流动式装置时，固定吸附剂颗粒的直径约为 1 µm 至约 200 µm；并且，在使用所述系统处理后，所述血液制品基本上保持了所需的生物活性。
• Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
  申请人：——

  公开号：US20020045228A1

  公开（公告）日：2002-04-18

  Methods and devices are provided for reducing the concentration of low molecular weight compounds in a biological composition containing cells while substantially maintaining a desired biological activity of the biological composition. The device comprises highly porous adsorbent particles, and the adsorbent particles are immobilized by an inert matrix.

  本发明提供了降低含有细胞的生物组合物中低分子量化合物浓度的方法和装置，同时基本保持了生物组合物所需的生物活性。该装置包括高多孔性吸附剂颗粒，吸附剂颗粒被惰性基质固定。